Literature DB >> 10508634

Adenovirus vectors for gene delivery.

K Benihoud1, P Yeh, M Perricaudet.   

Abstract

Recent endeavors in the development of adenovirus as a gene vector have focused on the modification of virus tropism, the accommodation of larger genes, and the increase in stability and control of transgene expression. Whereas partial or total deletions of viral genes increase the cloning capacity and partly reduce the cellular immune response, control of the humoral response, which often precludes efficient readministration, remains a challenge.

Entities:  

Mesh:

Year:  1999        PMID: 10508634     DOI: 10.1016/s0958-1669(99)00007-5

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  87 in total

Review 1.  The promise and potential hazards of adenovirus gene therapy.

Authors:  L S Young; V Mautner
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

2.  Chromosomal integration pattern of a helper-dependent minimal adenovirus vector with a selectable marker inserted into a 27.4-kilobase genomic stuffer.

Authors:  M Hillgenberg; H Tönnies; M Strauss
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

3.  Functional analysis of adenovirus protein IX identifies domains involved in capsid stability, transcriptional activity, and nuclear reorganization.

Authors:  M Rosa-Calatrava; L Grave; F Puvion-Dutilleul; B Chatton; C Kedinger
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  A new hybrid system capable of efficient lentiviral vector production and stable gene transfer mediated by a single helper-dependent adenoviral vector.

Authors:  Shuji Kubo; Kohnosuke Mitani
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

Review 5.  Gene delivery into primary T cells: overview and characterization of a transgenic model for efficient adenoviral transduction.

Authors:  Vincent Hurez; Robin D Hautton; James Oliver; R James Matthews; Casey K Weaver
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 6.  Gene therapy: light is finally in the tunnel.

Authors:  Huibi Cao; Robert S Molday; Jim Hu
Journal:  Protein Cell       Date:  2012-01-10       Impact factor: 14.870

7.  In vitro induction of anterior gradient-2-specific cytotoxic T lymphocytes by dendritic cells transduced with recombinant adenoviruses as a potential therapy for colorectal cancer.

Authors:  Hyun Ju Lee; Cheol Yi Hong; Mi Hyun Kim; Youn Kyung Lee; Thanh Nhan Nguyen-Pham; Byoung Chul Park; Deok Hwan Yang; Ik Joo Chung; Hyeoung Joon Kim; Je Jung Lee
Journal:  Exp Mol Med       Date:  2012-01-31       Impact factor: 8.718

8.  Study of hepatitis C virus entry in genetically humanized mice.

Authors:  Marcus Dorner; Charles M Rice; Alexander Ploss
Journal:  Methods       Date:  2012-06-08       Impact factor: 3.608

9.  The transduction of Coxsackie and Adenovirus Receptor-negative cells and protection against neutralizing antibodies by HPMA-co-oligolysine copolymer-coated adenovirus.

Authors:  Chung-Huei K Wang; Leslie W Chan; Russell N Johnson; David S H Chu; Julie Shi; Joan G Schellinger; André Lieber; Suzie H Pun
Journal:  Biomaterials       Date:  2011-09-28       Impact factor: 12.479

10.  Exploitation of nucleic acid packaging signals to generate a novel influenza virus-based vector stably expressing two foreign genes.

Authors:  Tokiko Watanabe; Shinji Watanabe; Takeshi Noda; Yutaka Fujii; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.